These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 6154517

  • 1. The role of biologic tumor markers in testicular cancer.
    Javadpour N.
    Cancer; 1980 Apr 15; 45(7 Suppl):1755-61. PubMed ID: 6154517
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Serial monitoring of serum alpha-fetoprotein and chorionic gonadotropin in males with germ cell tumors.
    Thompson DK, Haddow JE.
    Cancer; 1979 May 15; 43(5):1820-9. PubMed ID: 87255
    [No Abstract] [Full Text] [Related]

  • 6. Hormonal changes in urine and plasma by hormone-producing testicular tumors before and after treatment.
    Lindenmeyer D, Tomanek M, Körner F.
    Acta Endocrinol Suppl (Copenh); 1971 May 15; 152():26. PubMed ID: 5279415
    [No Abstract] [Full Text] [Related]

  • 7. Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
    Lange PH.
    Natl Cancer Inst Monogr; 1978 Dec 15; (49):215-7. PubMed ID: 86163
    [Abstract] [Full Text] [Related]

  • 8. [Tumor markers in germ cell tumors. Clinical use and research aspects].
    Clausen PP, Nørgaard-Pedersen B, Arends J, Ingild A, Jacobsen GK, Jacobsen M, Juhl BR, Kjaersgaard E, Nissen MH, Schultz-Larsen P, Toftager-Larsen K, Zeuthen J.
    Ugeskr Laeger; 1982 May 03; 144(18):1285-90. PubMed ID: 6181594
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum alpha fetoprotein and human chorionic gonadotropin in the diagnosis and management of nonseminomatous germ-cell testicular cancer.
    Lange PH, McIntire KR, Waldmann TA, Hakala TR, Fraley EE.
    N Engl J Med; 1976 Nov 25; 295(22):1237-40. PubMed ID: 62281
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Serum alpha fetoprotein and testicular tumors.
    N Engl J Med; 1977 Mar 24; 296(12):693-4. PubMed ID: 65733
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of seminoma: does a positive HCG influence prognosis?
    Bartsch G, Mikuz G, Frommhold H, Scheiber K.
    Prog Clin Biol Res; 1985 Mar 24; 203():483-4. PubMed ID: 2421340
    [No Abstract] [Full Text] [Related]

  • 20. False-positive and false-negative alpha-feto protein and human chorionic gonadotropin assays in testicular cancer: a double blind study.
    Javadpour N, Soares T.
    Cancer; 1981 Nov 15; 48(10):2279-81. PubMed ID: 6170418
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.